SUMMARY. Serum total sialic acid (TSA) has gained medical interest, particularly as a cardiovascular risk factor and it has been hypothesized that serum levels relate to serum acute phase proteins, some of which are sialylated. We assayed serum TSA and also lipid associated sialic acid (LASA) in 50 normal individuals (24 male) and 15 subjects (12 male) who had experienced a myocardial infarct. The mean serum TSA in the normal individuals was 2'05 SD 0·38 mmol/L (range 1'16-2'74) and the mean serum LASA was 0.70SD 0·19mmo1lL (range 0'23-1'03). We also measured five serum acute phase proteins and found a good correlation between these and serum TSA: C-reactive protein, r=0.52, P<O.OOI, a-l-antichymotrypsin, r=0'79, P<O'OOOI, a-2-macroglobulin, r=0'38, P<O'OI and o-l-acid glycoprotein, r=0'32, P<0·05. A significant correlation between plasma TSA and plasma Creactive protein (r= 0'47, P<O·04) and also fibrinogen (r= O'53, P< 0'04) was noted on day one following the myocardial infarction, whereas a significant correlation between plasma TSA and plasma a-l-antichymotrypsin (r = O' 51, P < O' 03) and also plasma o-J-acid glycoprotein (r=O'64, P<0'05) was found on day two following the infarction. Thus it would seem that serum TSA is at least in part related to some of the acute phase proteins in both healthy individuals and those having had a myocardial infarction.
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There has been considerable recent interest in the measurement of serum sialic acid. Serum total sialic acid (TSA) has been shown to be a cardiovascular risk factor, with elevated levels associated with increased cardiovascular mortality'v' and also cerebrovascular disease. J Serum TSA and also serum lipid-associated sialic acid (LASA) are elevated in diabetes mellitus'<' and the former is associated with certain diabetic complications such as retinopathy." Furthermore, serum TSA is elevated after myocardial infarction 7 ,8 chronic glornerulonephritis? and also in patients with hypertriglyceridaemia.l? Both serum TSA and serum LASA have also been used as tumour markers for a number of different cancers, including malignant melanoma, breast carcinoma and colon carcinoma.U':" Correspondence: Dr M Crook.
Despite these observations it is unclear why serum TSA is elevated in these disorders. A possible relationship between serum TSA and some of the acute phase proteins has been reported in a small group of human subjects." However, these workers did not study serum LASA and their study was limited in regard to the acute phase proteins studied, particularly in normal healthy subjects. The purpose of our study was to test the hypothesis that serum TSA may be related to certain acute phase proteins in healthy individuals. This hypothesis was based upon the fact that some of the acute phase proteins are glycoproteins with sialicacid residues at the terminal ends of their carbohydrate side-chains.
METHODS

Subjects
Fifty healthy subjects were recruited who did not have hypertension or diabetes mellitus and were Furthermore, serum albumin and serum total protein were assayed using a Kodak Ektachem analyser (Kodak Ltd, USA). The reason for studying the MI patients was to ascertain whether features relating to acute phase proteins and TSA in healthy subjects were specific or whether they were also present in subjects in whom an acute phase response was known to occur. A MI is a particularly useful acute phase protein model as the timing of the initial event is relatively easy and thus the acute phase response can be followed from this time. As we had found no significant difference between plasma or serum TSA or LASA we chose to use plasma samples in this part of the study so that we could also measure fibrinogen, an acute phase protein and a reputed cardiovascular risk factor. Assays Serum TSA was assayed using an enzymatic method purchased from Boehringer Mannheim (Lewes, Sussex, UK) and adapted for use on a Roche Cobas Bio auto-analyser. This method uses a coupled enzyme assay reaction, incorporating neuraminidase, N-acetylneuraminic acid aldolase and pyruvate oxidase linked to a peroxidase dye system. The between batch coefficient of variation was 3·8%. Serum LASA concentration was measured by the method of Katopodis and Stock" as modified by Ozben? with between batch coefficient of variation of 7%. Serum LASA is perhaps a misnomer as it refers to sialic acid containing material after lipid solvent extraction and has been suggested to contain, in part, gangliosides. The following acute phase proteins were also assayed upon the same sample; C-reactive protein (CRP), o-l-acid glycoprotein (AGP) , o-l-antichymotrypsin (ACT), a-2-macroglobulin (AMG), albumin and total protein.
Haptoglobin and o-l-antitrypsin werenot measured as the former can be influenced by haemolysis and the latter by genetic variants of the protein. Serum globulin concentration was calculated as the difference between serum total protein and serum albumin concentrations.
Acute phase proteins, were assayed immunoturbidmetrically, using commercial kits from Binding Site (Binding Site Ltd, Birmingham, UK) adapted for use on a Cobas Mira analyser. not taking any medication. They also had no recent infections, operations or other illnesses including malignant disease. The age range of the 50 subjects recruited in the study was 18 to 62 years (mean 49 SD 16) and included 24 male and 26 female. In 20 of these subjects (selected at random) paired plasma and serum samples were taken and fibrinogen was also assayed in the plasma sample whilst TSA was measured in both the serum and plasma samples.
In testing the hypothesis that TSA is related to the acute phase proteins we also studied 15 patients (12 male, three female) with an acute myocardial infarction (MI). The mean age of the acute MI patients was 64 SD 11years. Myocardial infarction was diagnosed upon the basis of clinicalsymptoms, characteristic electrocardiogram changes, elevated total creatine kinase (CK) activity and CK-MB that was greater than 51110 of the total CK activity. Samples were collected from these patients at initial presentation (day 1), 48 h post-infarction (day 2) and five days postinfarction. Tables 4 and 5 show the correlation coefficients and significancevalues for plasma TSA and plasma LASA and the plasma acutephaseproteins (including fibrinogen) of the myocardial infarction subjects.
DISCUSSION
We are able to show that serum TSA correlates well with some of the acute phase proteins in normal individuals and also after a myocardial infarction. Of note is the strong correlation with serum ACT in normal subjects. This observation we believe is a novel finding and of interest as this acute phase protein is said to be elevated for longer and peaks later than CRP as a result of an acute phase response." In this context it is also of note that in the MI patients the significant correlation between plasma TSA and plasma ACf occurred on day two post-infarction, whereas that for plasma CRP manifested on the first day. It is important to note that CRP is thought not to be sialylated, although AGP and AMG are described as richly sialylated.'-" The relationship between TSA and the acute phase proteins was thus not just specific to normal subjects but also occurred in patients who had a MI, i.e. individuals who have elicited an acute phase response. We were unable to show differences in serum TSA between healthy males and females. This observation is in keeping with those of Hangloo et al. 18 who reported that there was no sex difference with respect to serum TSA in 50 normal individuals that they studied. Also in keeping with our findings they found no influence of subject age upon serum TSA concentration.
The serum LASA values we obtained were similar to those published by Ozben.? There was no sex difference for serum LASA and serum LASA did not correlate with the subject's age. We also noted a significant positive correlation with serum ACT and AGP and serum LASA and a negative correlation with albumin; this is a little concerning as it implies that serum LASA may not be entirely lipid bound sialic acid and may be contaminated with proteinaceous material. Indeed, Vegh et al. 19 have recently published data criticizing the Katopodis and Stock" assay for serum LASA. Until this issue is resolved our data suggests that great caution should be given to the interpretation of serum LASA results assayed by this method.
Interestingly, we have also shown a correlation between either plasma or serum TSA and plasma fibrinogen in both normals and MI patients. Fibrinogen has been shown to be a cardiovascular risk factor-" and these observations may in part explain why TSA has been reported as being a predictor of cardiovascular mortality. 2, 3 Our data fits with the observations that elevated acute phase proteins have been shown in the conditions referred to in the introduction of this paper in which raised serum TSA has also been observed. It is also noteworthy that it was proposed over a decade ago that in atherosclerosis there is a chronic inflammatory process involving acute phase proteins."
